PL2547217T3 - Żywienie niemowląt dla poprawienia składu kwasów tłuszczowych w błonach mózgowych - Google Patents

Żywienie niemowląt dla poprawienia składu kwasów tłuszczowych w błonach mózgowych

Info

Publication number
PL2547217T3
PL2547217T3 PL11712043T PL11712043T PL2547217T3 PL 2547217 T3 PL2547217 T3 PL 2547217T3 PL 11712043 T PL11712043 T PL 11712043T PL 11712043 T PL11712043 T PL 11712043T PL 2547217 T3 PL2547217 T3 PL 2547217T3
Authority
PL
Poland
Prior art keywords
fatty acid
acid composition
brain membranes
infant nutrition
improving fatty
Prior art date
Application number
PL11712043T
Other languages
English (en)
Inventor
Der Beek Eline Marleen Van
Marieke Abrahamse-Berkeveld
Annemiek Lidewij Schipper
Gelske Speelmans
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43487597&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2547217(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2547217T3 publication Critical patent/PL2547217T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/01—Other fatty acid esters, e.g. phosphatides
    • A23D7/011—Compositions other than spreads
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/02—Other edible oils or fats, e.g. shortenings or cooking oils characterised by the production or working-up
    • A23D9/04—Working-up
    • A23D9/05—Forming free-flowing pieces
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J7/00—Phosphatide compositions for foodstuffs, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A23P10/35—Encapsulation of particles, e.g. foodstuff additives with oils, lipids, monoglycerides or diglycerides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pediatric Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL11712043T 2010-03-17 2011-03-17 Żywienie niemowląt dla poprawienia składu kwasów tłuszczowych w błonach mózgowych PL2547217T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2010/050142 WO2011115476A1 (en) 2010-03-17 2010-03-17 Infant nutrition for improving fatty acid composition of brain membranes later in life
EP11712043.6A EP2547217B1 (en) 2010-03-17 2011-03-17 Infant nutrition for improving fatty acid composition of brain membranes
PCT/NL2011/050188 WO2011115491A1 (en) 2010-03-17 2011-03-17 Infant nutrition for improving fatty acid composition of brain membranes

Publications (1)

Publication Number Publication Date
PL2547217T3 true PL2547217T3 (pl) 2018-01-31

Family

ID=43487597

Family Applications (3)

Application Number Title Priority Date Filing Date
PL11712042T PL2547216T3 (pl) 2010-03-17 2011-03-17 Żywienie niemowląt dla poprawy kompozycji kwasów tłuszczowych błon mózgowych
PL17201407.8T PL3332649T3 (pl) 2010-03-17 2011-03-17 Sposób nieterapeutycznej poprawy wyników behawioralnych dzięki użyciu pożywienia dla niemowląt
PL11712043T PL2547217T3 (pl) 2010-03-17 2011-03-17 Żywienie niemowląt dla poprawienia składu kwasów tłuszczowych w błonach mózgowych

Family Applications Before (2)

Application Number Title Priority Date Filing Date
PL11712042T PL2547216T3 (pl) 2010-03-17 2011-03-17 Żywienie niemowląt dla poprawy kompozycji kwasów tłuszczowych błon mózgowych
PL17201407.8T PL3332649T3 (pl) 2010-03-17 2011-03-17 Sposób nieterapeutycznej poprawy wyników behawioralnych dzięki użyciu pożywienia dla niemowląt

Country Status (10)

Country Link
US (4) US9474764B2 (pl)
EP (4) EP3272221A1 (pl)
CN (3) CN102905542B (pl)
BR (2) BR112012023264A8 (pl)
ES (3) ES2656154T3 (pl)
MY (1) MY166016A (pl)
PH (2) PH12012501823A1 (pl)
PL (3) PL2547216T3 (pl)
RU (4) RU2560861C2 (pl)
WO (3) WO2011115476A1 (pl)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY159212A (en) * 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
EP2806736A4 (en) * 2011-10-21 2015-10-14 Omthera Pharmaceuticals Inc METHODS AND COMPOSITIONS FOR TREATMENT OR PREVENTION OF HYPERACTIVITY DISORDER WITH ATTENTION DEFICIT
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2014058301A1 (en) * 2012-10-12 2014-04-17 N.V. Nutricia Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life
US10455854B2 (en) 2013-03-11 2019-10-29 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9661874B2 (en) 2013-03-11 2017-05-30 Mead Johnson Nutrition Company Nutritional compositions containing structured fat globules and uses thereof
US9980506B2 (en) 2013-03-11 2018-05-29 Mead Johnson Nutrition Co. Nutritional compositions containing structured fat globules and uses thereof
US10709770B2 (en) 2013-07-31 2020-07-14 Mead Johnson Nutrition Company Nutritional compositions containing a prebiotic and lactoferrin and uses thereof
US9609888B2 (en) * 2013-07-31 2017-04-04 Mead Johnson Nutrition Company Nutritional compositions containing synergistic combination and uses thereof
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
RU2689550C1 (ru) * 2013-12-12 2019-05-28 Нестек С.А. Искусственные молочные композиции, содержащие полиненасыщенные жирные кислоты (ПНЖК), для содействия здоровому развитию когнитивной функции у младенцев и детей младшего возраста мужского и женского пола
US20170273343A1 (en) * 2014-08-15 2017-09-28 N.V. Nutricia Lipid composition for improving behaviour
FR3026918B1 (fr) * 2014-10-13 2018-02-23 Even Sante Industrie Procede d'obtention d'un lait infantile pret a l'emploi et de longue conservation
WO2016086157A1 (en) * 2014-11-26 2016-06-02 Abbott Laboratories Infant formula comprising human milk oligosaccharides, polyunsaturated fatty acids, nucleotides, and lutein
EP3280277B1 (en) * 2015-04-10 2021-06-30 N.V. Nutricia Use of a nutritional composition with large lipid globules comprising vegetable fat coated with milk phospholipids for lipid digestion
US10582714B2 (en) 2015-07-10 2020-03-10 Mead Johnson Nutrition Company Nutritional compositions and methods for promoting cognitive development
US10617701B2 (en) 2015-07-10 2020-04-14 Mead Johnson Nutrition Company Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
EP3337487B1 (en) * 2015-08-17 2021-02-24 ST IP Holding AG Honokiol and magnolol formulations with increased stability and improved uptake, and methods of use thereof
PL3574771T3 (pl) 2015-10-15 2023-03-13 N.V. Nutricia Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu
WO2017117121A1 (en) * 2015-12-28 2017-07-06 Abbott Laboratories Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof
BR112018071493A2 (pt) * 2016-04-18 2019-02-19 N.V. Nutricia usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce
WO2017183956A1 (en) * 2016-04-18 2017-10-26 N.V. Nutricia Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline
PT4082334T (pt) 2016-11-04 2025-05-21 Regeneron Pharma Animais não humanos possuindo um lócus da cadeia leve lambda de immunoglobulina geneticamente modificada
MY196605A (en) 2016-12-09 2023-04-20 Nutricia Nv Nutritional Composition for Improving Cell Membranes
CN110678086B (zh) * 2017-03-29 2023-10-20 N·V·努特里奇亚 用于改善的饮食行为的婴儿配方物
US20210100274A1 (en) * 2018-04-03 2021-04-08 N.V. Nutricia Nutritional composition for use in the prevention of dry skin
BR112022014436A2 (pt) * 2020-01-31 2022-09-13 Nutricia Nv Método não terapêutico de modulação do tempo e resultado da maturação intestinal em bebês
JPWO2021200698A1 (pl) * 2020-04-01 2021-10-07
WO2023208925A1 (en) 2022-04-25 2023-11-02 N.V. Nutricia Nutritional composition for use in preventing programmed obesity in female infants
WO2023232882A1 (en) 2022-05-31 2023-12-07 N.V. Nutricia Infant formula for improving cognitive development
AU2023389031A1 (en) * 2022-12-06 2025-05-29 N.V. Nutricia Infant formula for improving cognitive development
EP4661697A1 (en) 2023-02-07 2025-12-17 N.V. Nutricia Nutritional composition with improved segregation resistance
WO2025207721A1 (en) * 2024-03-26 2025-10-02 Cargill, Incorporated Lc-pufa enriched oleosome composition
WO2025207712A1 (en) * 2024-03-26 2025-10-02 Cargill, Incorporated Lipid enriched oleosome composition
WO2026033137A1 (en) 2024-08-08 2026-02-12 N.V. Nutricia Particulate nutritional composition with large lipid globules
WO2026033138A1 (en) 2024-08-09 2026-02-12 N.V. Nutricia Nutritional composition with large lipid globules and native protein

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1084006A1 (ru) 1981-11-09 1984-04-07 Казахский Филиал Института Питания Амн Ссср Способ приготовлени пищевой эмульсии
NL8800629A (nl) 1988-03-15 1989-10-02 Ver Coop Melkind Gesproeidroogd melkpoederprodukt en werkwijze voor de bereiding daarvan.
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
IL119982A (en) 1997-01-09 2000-07-26 Shapira Niva Bottle for infant feeding
AU745551B2 (en) 1997-03-27 2002-03-21 Bristol-Myers Squibb Company Use of docosahexanoic acid and arachidonic acid enhancing the growth of preterm infants
JP2001158736A (ja) 1999-11-30 2001-06-12 Snow Brand Milk Prod Co Ltd 骨関節疾患の予防及び改善剤
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
US6620427B2 (en) 2001-04-24 2003-09-16 Abbott Laboratories Method for improving bone mineralization
WO2003005836A2 (en) 2001-07-10 2003-01-23 Trustees Of Boston University Modified-fat nutritional products useful for preventing or treating obesity
US6902739B2 (en) 2001-07-23 2005-06-07 Nutracea Methods for treating joint inflammation, pain, and loss of mobility
JP4446962B2 (ja) 2003-07-16 2010-04-07 出光興産株式会社 樹脂材料への超音波振動付与装置、この超音波振動付与装置を用いた樹脂材料の溶融成形方法及び樹脂組成物
WO2005016265A2 (en) 2003-08-06 2005-02-24 Rhodia Inc. Method for promoting bone growth
IL158554A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Mimetic lipids as dietary supplements
IL158555A0 (en) 2003-10-22 2004-05-12 Enzymotec Ltd Human breast milk lipid mimetic as dietary supplement
JP2007515402A (ja) 2003-11-20 2007-06-14 アルターアゴン プロプライエタリー リミテッド 哺乳動物および鳥類の体脂肪および体重の減少方法
WO2005063050A1 (en) 2003-12-19 2005-07-14 Abbott Laboratories Method of increasing lean body mass and reducing body fat mass in infants
US8252769B2 (en) * 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1811867A2 (en) 2004-11-12 2007-08-01 N.V. Nutricia Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
WO2006094999A1 (en) 2005-03-08 2006-09-14 Nestec S.A. Extruded solid product for use in foodstuffs
US20060210697A1 (en) 2005-03-18 2006-09-21 Mower Thomas E Infant formula composition
RU2480474C2 (ru) * 2005-04-28 2013-04-27 Энзимотек Лтд. Смеси полярных липидов, их получение и применение
TWI282268B (en) 2005-09-15 2007-06-11 Univ Chung Shan Medical Medical image system and method for measuring vertebral axial rotation
US7311676B2 (en) 2005-09-23 2007-12-25 Park Sangdo Portable non-invasive device for measuring the hardness of muscle or muscle compartment
CA2624921C (en) 2005-10-05 2012-07-10 Nestec S.A. Nutritional formulation for promoting catch-up growth
WO2008054192A1 (en) 2006-11-02 2008-05-08 N.V. Nutricia Use of nutritional compositions for preventing disorders
PL1800675T4 (pl) 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
BRPI0620465A2 (pt) * 2005-12-23 2011-11-16 Nutricia Nv uso de uma composição
KR100598607B1 (ko) 2006-02-24 2006-07-07 주식회사 일신웰스 유지 조성물 및 이의 제조방법
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
WO2008003330A1 (en) * 2006-07-07 2008-01-10 Danmarks Tekniske Universitet (Technical University Of Denmark) Variable trailing edge section geometry for wind turbine blade
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
WO2008081934A1 (ja) 2006-12-28 2008-07-10 Meiji Dairies Corporation 乳由来リン脂質を含有する乳幼児脳発達促進剤及びそれを含有する食品組成物
PL2211629T3 (pl) 2007-10-19 2020-11-16 Fonterra Co-Operative Group Limited Sposoby podtrzymania albo poprawy wzrostu lub rozwoju kognitywnego
MX2010004820A (es) * 2007-11-01 2010-08-10 Enzymotec Ltd Mezcla lipidica para nutricion infantil.
WO2009066685A1 (ja) 2007-11-19 2009-05-28 Snow Brand Milk Products Co., Ltd. 感覚改善剤
FR2930406B1 (fr) 2008-04-29 2011-04-15 Groupe Lactalis Aliment infantile a base de matiere grasse d'origine laitiere
BRPI0915337B1 (pt) 2008-06-16 2019-09-24 N.V. Nutricia Uso de gordura vegetal, proteína e carboidrato e da fórmula líquida de leite para bebê, recipiente contendo uma fórmula líquida de leite para bebê, processo para preparar uma fórmula líquida de leite para bebê, uso da fórmula líquida de leite para bebê, fórmula líquida de leite para bebê e pó
MY159212A (en) 2008-09-02 2016-12-30 Nutricia Nv Nutritional compositions with coated lipid globules
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
WO2010070613A2 (en) 2008-12-18 2010-06-24 University College London Baby feeding formula and system
WO2010134800A1 (en) 2009-05-19 2010-11-25 N.V. Nutricia Human milk fortifier with high protein and long chain poly unsaturated fatty acids for improving body adipose tissue distribution
WO2011071367A1 (en) 2009-12-11 2011-06-16 N.V. Nutricia Metabolic imprinting effects of structured lipids
WO2011108918A1 (en) 2010-03-04 2011-09-09 N.V. Nutricia Modulation of post-prandial fat absorption
WO2011115476A1 (en) 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
WO2012173467A1 (en) 2011-06-16 2012-12-20 N.V. Nutricia Metabolic imprinting effects of specifically designed lipid component
WO2013036102A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with cholesterol
WO2013036104A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Infant nutrition for regulating food intake later in life
WO2013036103A1 (en) 2011-09-08 2013-03-14 N.V. Nutricia Use of infant formula with large lipid globules
EP2583562A1 (en) 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
SE536599C3 (sv) 2012-04-10 2017-01-10 Hero Ag Näringssammansättning med lågt kalori- och lågt proteininnehåll
WO2013191533A1 (en) 2012-06-18 2013-12-27 N.V. Nutricia Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat
BR112016009351B1 (pt) 2013-11-01 2020-12-22 N.V. Nutricia Uso de lipídio para a preparação de uma composição nutricional e fórmula para recémnascidos
RU2638323C1 (ru) 2013-11-29 2017-12-13 Нестек С.А. Применение питательных композиций с низким количеством белка
AU2014368585A1 (en) 2013-12-19 2016-05-19 Nestec S.A. Nutritional composition for use in reducing metabolic stress in infants, decreasing gut permeability and approximating growth rate of breast-fed infants

Also Published As

Publication number Publication date
RU2015127482A3 (pl) 2018-12-24
EP3332649A1 (en) 2018-06-13
WO2011115476A1 (en) 2011-09-22
EP2547217B1 (en) 2017-07-19
EP3332649B1 (en) 2024-04-24
CN104351796A (zh) 2015-02-18
RU2012144016A (ru) 2014-04-27
US20150306117A1 (en) 2015-10-29
US9474764B2 (en) 2016-10-25
EP2547217A1 (en) 2013-01-23
RU2692627C2 (ru) 2019-06-25
CN102905542A (zh) 2013-01-30
PL2547216T3 (pl) 2018-04-30
EP2547216A1 (en) 2013-01-23
US20130096087A1 (en) 2013-04-18
RU2015127482A (ru) 2018-12-24
BR112012023264A8 (pt) 2015-10-20
EP3272221A1 (en) 2018-01-24
RU2015130598A3 (pl) 2018-12-24
MY166016A (en) 2018-05-21
CN102905542B (zh) 2014-10-22
BR112012023264A2 (pt) 2015-09-15
RU2015130598A (ru) 2018-12-24
US20170151203A1 (en) 2017-06-01
ES2656154T3 (es) 2018-02-23
RU2012144021A (ru) 2014-04-27
BR112012023267A2 (pt) 2017-10-03
PL3332649T3 (pl) 2024-10-07
EP2547216B1 (en) 2017-11-15
ES2642635T3 (es) 2017-11-17
WO2011115490A1 (en) 2011-09-22
US10548869B2 (en) 2020-02-04
PH12012501824A1 (en) 2022-10-05
RU2560861C2 (ru) 2015-08-20
RU2559113C2 (ru) 2015-08-10
RU2692920C2 (ru) 2019-06-28
ES2992192T3 (es) 2024-12-10
PH12012501823A1 (en) 2012-11-12
US20130071446A1 (en) 2013-03-21
WO2011115491A1 (en) 2011-09-22
CN102892300B (zh) 2016-03-30
CN102892300A (zh) 2013-01-23

Similar Documents

Publication Publication Date Title
PL2547216T3 (pl) Żywienie niemowląt dla poprawy kompozycji kwasów tłuszczowych błon mózgowych
EP2917358A4 (en) COMPOSITIONS AND METHODS FOR THE BIOLOGICAL PRODUCTION OF FATTY ACID DERIVATIVES
HRP20181696T1 (hr) Postupak za pripremu dipeptidnih derivata lizin-glutaminske kiseline
ZA201308606B (en) Nutritional compositions having alpha-hica and eicosapentaenoic acid
PH12012500561A1 (en) Production of fatty acid derivatives
EP2417246A4 (en) PRODUCTION OF FATTY ACID DERIVATIVES
PL2609120T3 (pl) Ulepszony sposób wytwarzania sugammadeksu
PL2352497T3 (pl) Proces przygotowania estrów aminokwasowych delta-9-thc
SG11201501013PA (en) Microorganisms and methods for the production of fatty acids and fatty acid derived products
EP2457987A4 (en) METHOD FOR PRODUCING TRIPLE SATURATED FATTY ACID GLYCERIDE-CONTAINING FAT COMPOSITIONS
EP2755955A4 (en) METHOD FOR PRODUCING SUBSTITUTED 3'-HYDRAZIN BIPHENYL-3-CARBOXYLIC ACID COMPOUNDS
EP2789601A4 (en) PROCESS FOR PREPARING A FATTY ACID MONOGLYCERIDE-BASED MIXTURE
GB201001345D0 (en) Process for preparing and purifying fatty acids
IL220211A0 (en) Process for the preparation of 1-alkyl-/1-aryl-5-pyrazolecarboxylic acid derivatives
SI2906587T1 (sl) Metode in sestave za izboljšano proizvodnjo maščobnih kislin in njihovih derivatov
IL233132A0 (en) Process for the preparation of esters of 5-fluoro-2-methyl-3-quinoline-2-ylmethylindol-1-yl-acetic acid
EP2807143A4 (en) PROCESS FOR THE PREPARATION OF FINGOLIMODE
HUE040143T2 (hu) Folyamatos eljárás (S)-2-acetiloxipropionsav elõállítására
PT2735558T (pt) Processo para síntese direta de ácido láctico
PL2791201T3 (pl) Sposób wytwarzania określonych funkcjonalnych oligomerów kwasu mlekowego
EP2791349A4 (en) SYNTHESIS OF N-ACETYL-D-NEURAMIC ACID
GB2503103B (en) Process for the production of fatty acid esters
LT2673282T (lt) Drono rūgščių naujas gavimo būdas
PL390970A1 (pl) Enancjomer δ-aminokwasu gem-dimetylocyklopropanu i sposób jego wytwarzania
PL390968A1 (pl) Enancjomer δ-aminokwasu gem-dimetylocyklopropanu i sposób jego wytwarzania